DoubleLine ETF Adviser LP Has $366,000 Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

DoubleLine ETF Adviser LP lessened its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 5.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 30,221 shares of the pharmacy operator’s stock after selling 1,865 shares during the quarter. DoubleLine ETF Adviser LP’s holdings in Walgreens Boots Alliance were worth $366,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Iron Horse Wealth Management LLC increased its holdings in shares of Walgreens Boots Alliance by 162.5% in the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 1,300 shares in the last quarter. Pineridge Advisors LLC acquired a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at approximately $26,000. Blue Trust Inc. boosted its position in shares of Walgreens Boots Alliance by 87.0% during the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 1,081 shares in the last quarter. Quest Partners LLC bought a new position in Walgreens Boots Alliance during the fourth quarter worth about $30,000. Finally, Continuum Advisory LLC grew its position in shares of Walgreens Boots Alliance by 71.2% in the 2nd quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 1,020 shares during the period. Institutional investors own 58.59% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on WBA. UBS Group reduced their price objective on Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating for the company in a research report on Wednesday, July 3rd. Evercore ISI dropped their price target on Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating on the stock in a research note on Friday, June 28th. JPMorgan Chase & Co. cut their price objective on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, August 30th. Royal Bank of Canada reduced their target price on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research report on Tuesday, July 2nd. Finally, Bank of America lowered their price target on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a research report on Wednesday, September 4th. Four research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus price target of $14.73.

Walgreens Boots Alliance Stock Up 3.3 %

Shares of Walgreens Boots Alliance stock opened at $8.52 on Friday. The stock’s 50-day moving average is $10.09 and its 200 day moving average is $14.46. Walgreens Boots Alliance, Inc. has a one year low of $8.22 and a one year high of $27.05. The firm has a market cap of $7.36 billion, a price-to-earnings ratio of -1.26, a PEG ratio of 0.97 and a beta of 0.70. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.65 and a quick ratio of 0.31.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). The business had revenue of $36.40 billion for the quarter, compared to the consensus estimate of $35.94 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. Walgreens Boots Alliance’s quarterly revenue was up 2.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.00 earnings per share. Equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 2.86 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, September 12th. Investors of record on Wednesday, August 21st were paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 11.74%. The ex-dividend date was Wednesday, August 21st. Walgreens Boots Alliance’s dividend payout ratio is presently -14.84%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.